A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2011
12/01/2011	US20110294788 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
12/01/2011	US20110294781 Pyrazolo-pyrimidine compounds
12/01/2011	US20110294737 Terminally-differentiated anucleate platelet progeny generation
12/01/2011	US20110294733 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof
12/01/2011	US20110294732 Erythropoletin complementation or replacement
12/01/2011	US20110294727 Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
12/01/2011	US20110293748 Combined preparation for treating sepsis
12/01/2011	US20110293733 Self-assembling nanoparticle drug delivery system
12/01/2011	US20110293725 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293722 Hydrogel sponges, methods of producing them and uses thereof
12/01/2011	US20110293711 Utilization of Dialkylfumarates
12/01/2011	US20110293689 Immobilized biologically active entities having a high degree of biological activity
12/01/2011	US20110293681 Hand sanitizing patch having an integrally bonded antimicrobial
12/01/2011	US20110293669 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293633 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenic purpura (nait)
12/01/2011	US20110293617 Anti-p-selectin antibodies and methods of their use and identification
12/01/2011	US20110293602 Vegf-like factor antibodies and methods of use thereof
12/01/2011	US20110293601 Composition and method for treatment of reperfusion injury and tissue damage
12/01/2011	US20110293597 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
12/01/2011	US20110293594 Removal of serine proteases by treatment with finely divided silicon dioxide
12/01/2011	US20110293582 Methods for enhancing hematopoietic stem/progenitor cell engraftment
12/01/2011	US20110293575 Photochemical internalisation of kinase inhibitors
12/01/2011	US20110293574 Hematopoietic stem cell growth factor
12/01/2011	US20110293564 2-morpholino-pyrido[3,2-d]pyrimidines
12/01/2011	US20110293522 Surface modification of polymers via surface active and reactive end groups
11/2011
11/30/2011	EP2390270A1 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
11/30/2011	EP2389954A1 Cytotoxic antibodies directed against factor VIII inhibitor antibodies
11/30/2011	EP2389943A1 Use of IL-174 antagonists for treating Th2-related diseases
11/30/2011	EP1409025B1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies
11/30/2011	EP1329461B1 Method of eliminating human serum albumin polymers
11/30/2011	CN1984655B 可用于治疗血栓形成性疾病的p2y1受体脲拮抗剂 P2y1 receptors urea useful in the treatment of thrombotic diseases antagonists
11/30/2011	CN102260698A 大肠杆菌中表达PTA-linker-thanatin融合蛋白及其抗癌研究 PTA-linker-thanatin fusion proteins expressed in E. coli and cancer research
11/30/2011	CN102260350A 人鼠嵌合型抗人CD14抗体Hm2F9及用途 Human-mouse chimeric anti-human CD14 antibodies and uses Hm2F9
11/30/2011	CN102260313A 无定形态人参皂苷Rb1及其制备方法 Amorphous ginsenosides Rb1 and its preparation method
11/30/2011	CN102260276A 普拉格雷枸橼酸盐及其制备方法 Prasugrel citrate and its preparation method
11/30/2011	CN102260275A 氢溴酸普拉格雷及其药物组合物和应用 Prasugrel hydrobromide and pharmaceutical compositions thereof and applications
11/30/2011	CN102260270A N-(2-甲基呋喃[2，3-d]嘧啶-4-基)丙烯酰胺、其制备方法及其用途 N- (2- methyl-furo [2,3-d] pyrimidin-4-yl) acrylamide, their preparation and their use
11/30/2011	CN102260259A 四氢吡咯并吡嗪二酮并-[1-(N-乙基氨基酸)-四氢-β-咔啉]及其合成方法和应用 Tetrahydro pyrrolopyrazine dione and - [1- (N- ethyl-amino) - tetrahydro -β- carboline] and synthesis method and application
11/30/2011	CN102260252A 可用于治疗细菌感染的新噁唑烷酮 New oxazolidinone useful for treating bacterial infections
11/30/2011	CN102260242A 甲磺酸伊马替尼多晶型物及其药用组合物 Imatinib mesylate polymorphs and pharmaceutical compositions
11/30/2011	CN102260233A 3-丁基-1(3h)-异苯并呋喃酮衍生物及其制备方法 3-butyl--1 (3h) - -isobenzofuranone derivatives and preparation method
11/30/2011	CN102258784A 用于预防和治疗败血症的方法与组合物 For the prevention and treatment of sepsis methods and compositions
11/30/2011	CN102258770A 一种安全高效的冻干纤维蛋白封闭剂及其制备方法 A safe and effective freeze-dried fibrin sealant and its preparation method
11/30/2011	CN102258764A 21（r）阿加曲班的应用 21 (r) applications argatroban
11/30/2011	CN102258758A 一种高含量液体姜辣素及其制备方法 Of a high liquid content Gingerols its preparation method
11/30/2011	CN102258717A 一种治疗鞘膜积液的中药 A treatment for hydrocele medicine
11/30/2011	CN102258706A 一种中药保健酒 A traditional Chinese medicine health wine
11/30/2011	CN102258690A 用于治疗十二指肠出血、消化道出血的中药组合物 For the treatment of duodenal bleeding, gastrointestinal bleeding herbal composition
11/30/2011	CN102258684A 一种具有治疗和保健作用的中药配方 Kind of treatment and health effects of Chinese herbal formula
11/30/2011	CN102258679A 一种中药组合物、制备方法及其应用 Chinese medicinal composition, preparation method and application
11/30/2011	CN102258637A 裸花紫珠提取物及其制备方法和应用 Luohuazizhu extract and its preparation method and application
11/30/2011	CN102258634A 一种从广东紫珠中提取总苯丙素苷的方法 An extract from the Guangdong Callicarpa total phenylpropanoid glycosides method
11/30/2011	CN102258593A 一种用于肿瘤辅助治疗的中药组合物及制备方法和用途 Chinese medicine composition for the adjuvant treatment of cancer and preparation and use
11/30/2011	CN102258588A 芍药总苷的制备方法 Preparation of total glucosides of peony
11/30/2011	CN102258535A 兽用复方右旋糖酐铁注射液制备方法及对小鼠生长的影响 Compound veterinary iron dextran injection preparation methods and the impact on growth in mice
11/30/2011	CN102258483A 一种抗血栓的重组巴曲酶冻干制剂 An anti-thrombotic recombinant batroxobin lyophilized preparation
11/30/2011	CN101879206B Thrombolytic Chinese medicinal preparation
11/30/2011	CN101766799B 参附蜈蚣保健酒 Shenfu centipede health wine
11/30/2011	CN101549021B 杠板归药材的检测方法 Perfoliatum detection herbs
11/30/2011	CN101491595B 活脉调脂胶囊复方有效部位群的药物及制备工艺 Drug and preparation of live pulse Zhi Capsule Compound effective fractions of
11/30/2011	CN101461815B 三氟柳药物组合物及其制备方法 Triflusal pharmaceutical compositions and methods for preparing
11/30/2011	CN101455712B 一种治疗脑血栓病的中药组合物及其制备方法和用途 A method of treating cerebral disease medicine composition and its preparation method and use
11/30/2011	CN101376022B 含聚乙二醇降纤酶的药物组合物 Containing polyethylene glycol defibrase pharmaceutical compositions
11/30/2011	CN101301373B 一种补血口服液及其制备方法 One kind of blood oral liquid and its preparation method
11/30/2011	CN101284780B 5-位酰化莽草酸及其制备和应用 5-position acylated shikimic acid and its preparation and application
11/30/2011	CN101085226B 一种脉络宁注射用粉针剂及其制备方法 One kind Mailuoning powder for injection and its preparation method
11/30/2011	CN101085224B 一种脉络宁注射制剂的检测方法 Detection method Mailuoning injectable preparations
11/30/2011	CN101066335B 一种治疗血栓闭塞性脉管炎、静脉炎中成药及其制作方法 An Buerger, phlebitis medicine and its production method of treatment
11/29/2011	US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof
11/29/2011	US8067428 Platelet ADP receptor inhibitors
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067373 Therapeutic fibrin-derived peptides and uses thereof
11/29/2011	US8067367 Methods of increasing platelet and hematopoietic stem cell production
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2522535C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/29/2011	CA2484166C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2465757C Triazole derivatives as cyclooxygenase (cox) inhibitors
11/29/2011	CA2456327C Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/24/2011	WO2011145747A1 Prodrug of triazolone compound
11/24/2011	WO2011144916A1 Hemostatic compositions
11/24/2011	WO2011109356A3 Anti-coagulant infusion fluid source
11/24/2011	WO2011052950A3 Pharmaceutical composition comprising indole compound
11/24/2011	WO2010142461A3 Treatment of coagulopathy with hyperfibrinolysis
11/24/2011	US20110288462 Haemostatic wound care article
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011	US20110288147 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop
11/24/2011	US20110288122 Pharmaceutical Compositions and Administrations Thereof
11/24/2011	US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases
11/24/2011	US20110288046 Analysis of sulfated polysacchrides
11/24/2011	US20110288043 Maintenance of platelet inhibition during antiplatelet therapy
11/24/2011	US20110288040 Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors
11/24/2011	US20110288038 Hesperidin-containing composition
11/24/2011	US20110288019 Methods of increasing platelet and hematopoietic stem cell production
11/24/2011	US20110288018 Beverage lowering serum cholesterol
11/24/2011	US20110288017 Apo-lipoprotein propeptide

1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 671